Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the chronic cough market right now?
The market for chronic cough treatments has consistently expanded in the past years. Its value is expected to increase from $8.22 billion in 2024 to $8.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.3%. This uptick seen in the historical period can be associated with the higher incidence of underlying respiratory diseases, influences of the environment and air pollution, the use of tobacco and smoking, respiratory infections, and allergies, as well as sensitivities to environmental factors.
How fast Is the chronic cough market expected to grow, and what’s its future value?
The market size of chronic cough is projected to experience significant expansion in the coming years. The market is anticipated to reach $12.89 billion in 2029, progressing at a compound annual growth rate (CAGR) of 9.7%. Various factors contributing to the growth during the projected period include the emergence of therapies targeting specific pathways, an enriched understanding of cough related to reflux, global initiatives in stopping smoking, and policies related to environmental and occupational health. Noteworthy trends foreseen within the forecast duration encompass advancements in diagnostic technology, patient-centred outlooks, therapeutic breakthroughs in neurogenic cough, the application of telehealth for managing chronic cough, and research focusing on central sensitization.
Get your chronic cough market report here!
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
What are the leading drivers of growth in the chronic cough market?
The increasing incidence of cough is anticipated to spur the development of the chronic cough market. Coughing is a reflex action often triggered by irritation, mucus or foreign bodies, which aids in clearing the air passages by pushing out air from the lungs with force. A cough that persists for a minimum of eight weeks is categorized as chronic. Accordingly, the rise in cough cases correlates to a surge in chronic cough instances. As an example, in March 2022, as per the Florida Health, a US-based Department of Healthcare, 80 patients were reported in 2021, with incidences of 41.0 and 1.4 per 100,000 years respectively, in the US. In 2023, 28 pertussis cases were documented across 13 countries. Moreover, in March 2022, the Statens Serum Institut, a disease surveillance department based in Denmark, reported a 41% increase in pertussis cases from November 2022 to April 2023, compared against November 2021–April 2022 in Denmark. Therefore, the burgeoning prevalence of cough is fuelling the expansion of the chronic cough market.
What are the key segments defining the chronic cough market?
The chronic cough market covered in this report is segmented –
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route Of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
2) By Corticosteroids: Inhaled Corticosteroids, Systemic Corticosteroids
3) By Decongestants: Oral Decongestants, Nasal Decongestants
4) By Combination Drug: Antihistamine And Decongestant Combinations, Cough Suppressant And Expectorant Combinations
5) By Antibiotics: Macrolides, Penicillins, Cephalosporins
6) By Acid Blockers: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists
7) By Other Drug Classes: Mucolytics, Cough Suppressants, Herbal Remedies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp
Who are the key players steering the development of the chronic cough market?
Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.
What emerging trends are influencing the growth of the chronic cough market?
Prominent businesses in the chronic cough market are focusing on the development of novel products such as biosimilars in order to solidify their market standing. Chronically ill patients suffering from cancer, autoimmune diseases, and diabetes can benefit from these cost-effective substitutes to existing biologics. As per information from Sandoz, a pharmaceutical company based in Switzerland in July 2024, the company initiated the distribution of its biosimilar Pyzchiva (ustekinumab) throughout Europe. This medication targets chronic inflammatory diseases including plaque psoriasis, psoriatic arthritis, and Crohn’s disease. This biosimilar holds particular importance being the first of its nature accessible all across Europe, inclusive of all reference medicine strengths like the starting dose for Crohn’s disease. Developed in collaboration with Samsung Bioepis, Sandoz is focused on further increasing access to efficacious treatments for millions suffering from these diseases. The roll-out of this biosimilar showcases Sandoz’s dedication towards providing cost-effective healthcare alternatives, while enhancing the quality of life for patients all over Europe.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109
Which regions are most influential in expanding the chronic cough market?
North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Oil And Gas Upstream Activities Global Market Report 2024
Chemicals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
Medical And Diagnostic Laboratory Services Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
